347 related articles for article (PubMed ID: 32048711)
21. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.
Helpman L; Beiner ME; Aviel-Ronen S; Perri T; Hogen L; Jakobson-Setton A; Ben-Baruch G; Korach J
Fertil Steril; 2015 Jul; 104(1):138-44. PubMed ID: 25956371
[TBL] [Abstract][Full Text] [Related]
22. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract][Full Text] [Related]
23. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
[TBL] [Abstract][Full Text] [Related]
24. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
25. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
Falcone F; Breda E; Ferrandina G; Malzoni M; Perrone AM; Cormio G; Di Donato V; Frigerio L; Mangili G; Raspagliesi F; Festi A; Scibilia G; Biglia N; Sorio R; Vizza E; Losito NS; Greggi S
Gynecol Oncol; 2021 Jun; 161(3):825-831. PubMed ID: 33781554
[TBL] [Abstract][Full Text] [Related]
27. Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.
Lin W; Cao D; Shi X; You Y; Yang J; Shen K
Front Oncol; 2022; 12():856818. PubMed ID: 35860580
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
Jones BP; Saso S; Farren J; El-Bahrawy M; Ghaem-Maghami S; Smith JR; Yazbek J
Int J Gynecol Cancer; 2017 Nov; 27(9):1813-1818. PubMed ID: 28763365
[TBL] [Abstract][Full Text] [Related]
29. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours.
Jia SZ; Zhang JJ; Liang ZY; Yang JJ; Xiang Y; Jia CW; Leng JH
BMC Cancer; 2018 Nov; 18(1):1160. PubMed ID: 30470202
[TBL] [Abstract][Full Text] [Related]
30. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
[TBL] [Abstract][Full Text] [Related]
31. Management of borderline ovarian tumours.
Gershenson DM
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
[TBL] [Abstract][Full Text] [Related]
32. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
33. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
[TBL] [Abstract][Full Text] [Related]
34. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
Wang L; Zhong Q; Tang Q; Wang H
Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
[TBL] [Abstract][Full Text] [Related]
35. Oncologic and obstetric outcomes of early-stage epithelial ovarian cancer patients who underwent fertility-sparing surgery: A retrospective study.
Ayhan A; Tunç M; Atasoy Karakaş L; Tekelioğlu T; Haberal Reyhan AN; Önalan G; Kuşçu E
Int J Gynaecol Obstet; 2023 Aug; 162(2):711-717. PubMed ID: 36825554
[TBL] [Abstract][Full Text] [Related]
36. Recurrences and fertility after endometrioma ablation in women with and without colorectal endometriosis: a prospective cohort study.
Roman H; Quibel S; Auber M; Muszynski H; Huet E; Marpeau L; Tuech JJ
Hum Reprod; 2015 Mar; 30(3):558-68. PubMed ID: 25574030
[TBL] [Abstract][Full Text] [Related]
37. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.
Kajiyama H; Suzuki S; Niimi K; Tamauchi S; Kawai M; Nagasaka T; Shibata K; Kikkawa F
Int J Clin Oncol; 2019 Jul; 24(7):857-862. PubMed ID: 30771039
[TBL] [Abstract][Full Text] [Related]
38. Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database.
Falcone F; Malzoni M; Carnelli M; Cormio G; De Iaco P; Di Donato V; Ferrandina G; Raspagliesi F; Sorio R; Losito NS; Greggi S
Gynecol Oncol; 2022 May; 165(2):302-308. PubMed ID: 35232587
[TBL] [Abstract][Full Text] [Related]
39. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
[No Abstract] [Full Text] [Related]
40. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]